https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue for FY22
Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights
Categories
Health Care
Dr Lal PathLabs Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant shift towards
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive Chairman Om
Alkem Laboratories Ltd. (ALKEM) Q4 FY22 Earnings Concall Transcript
Alkem Laboratories Ltd. (NSE: ALKEM) Q4 FY22 Earnings Concall dated May. 13, 2022 Corporate Participants: Gagan Borana -- Investor Relations Sandeep Singh -- Managing Director Rajesh
Neuland Laboratories Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/SoKfArytP_s Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q4 FY22 Earnings Concall Management Update: NEULANDLAB said its capex plan is on track
Cipla Limited Q4 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=I-Ubq3MAmzg Key highlights from Cipla Limited (CIPLA) Q4 FY22 Earnings Concall Management Update: CIPLA said it crossed the $1 billion milestone in
SBI LIFE INSURANCE CO LTD (SBILIFE) Q4 2022 Earnings Call Transcript
SBI LIFE INSURANCE CO LTD (NSE: SBILIFE) Q4 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Mahesh Kumar Sharma -- Managing Director and
Laurus Labs Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/83rl6ffkU9c Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY22 Earnings Concall Management Update: LAURUSLABS said that based on its healthy product
Biocon Limited (BIOCON) Q4 2022 Earnings Concall Transcript
Biocon Limited (NSE: BIOCON) Q4 2022 earnings concall dated Apr. 29, 2022 Corporate Participants: Aishwarya Seetharam -- Head, Investor Relations Kiran Mazumdar Shaw -- Executive Chairperson
Glenmark Life Sciences Limited Q4 FY22 Earnings Conference Call Summary
https://youtu.be/au71QUL41tY Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&A Highlights: Neha Manpuria of Bank of America asked
Infographic: All you need to know about Apollo Hospital Q3 results
Apollo Hospitals(NSE:APOLLOHOSP) reported its third-quarter 2022 earnings results. The hospital chain had a consolidated revenue of ₹3,656 crores with a growth of
Max Healthcare Institute Ltd Q3 FY22 Earnings Conference Call Insights
https://youtu.be/vd7Dp7Vceio Key highlights from Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY22 Earnings Concall Management Update: MAXHELATH achieved the highest ever operating EBITDA
Solara Active Pharma Sciences Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/mZLf2s4bnQ8 Key highlights from Solara Active Pharma Sciences Limited (SOLARA) Q3 FY22 Earnings Concall Q&A Highlights: Kunal Randeria from Edelweiss asked about
Gufic Biosciences Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/f3tlyxhD91U Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY22 Earnings Concall Management Update: In CDMO, GUFICBIO said it’s looking at a
Sanofi India Ltd Q4 CY21 Earnings Conference Call Insights
https://youtu.be/D2vfw6hB5RI Key highlights from Sanofi India Ltd (SANOFI) Q4 CY21 Earnings Concall Q&A Highlights: Vipul Shah of RippleWave Equity asked if the
Sanofi India Ltd (SANOFI) Q4 FY21 Earnings Concall
Sanofi India Ltd (NSE:SANOFI) Q4 FY21 Earnings Concall dated Mar. 02, 2022
Prevest Denpro Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=ECd3N-qiOMo Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that since
Cupid Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/bwoNY3Y0LHo Key highlights from Cupid Limited (CUPID) Q3 FY22 Earnings Concall Management Update: CUPID stated that the top and bottom line performance
Orchid Pharma Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z2DK9xz1c8k Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY22 Earnings Concall Q&A Highlights: Viraj Kacharia from Securities Investment asked about the
JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=HiVTF6vv9q0 Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector with
MedPlus Health Services Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z_QNho0XdFU Key highlights from MedPlus Health Services Ltd (MEDPLUS) Q3 FY22 Earnings Concall Management Update: The company opened over 537 stores in